Modular Medical, Inc.: Form 10-Q for the period ended Mar 31, 2017
Filed with the SEC on May 18, 2017 and accepted by EDGAR at May 18, 2017, 13:49 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2017-01-01 to 2017-03-31 | $0 | us-gaap:Revenues |
| Revenue | 9 months2016-07-01 to 2017-03-31 | $0 | us-gaap:Revenues |
| Cost of revenue | 3 months2017-01-01 to 2017-03-31 | $0 | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months2016-07-01 to 2017-03-31 | $0 | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2017-01-01 to 2017-03-31 | $0 | us-gaap:GrossProfit |
| Gross profit | 9 months2016-07-01 to 2017-03-31 | $0 | us-gaap:GrossProfit |
| Operating income | 3 months2017-01-01 to 2017-03-31 | −$2.2k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2016-07-01 to 2017-03-31 | −$10.9k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2017-01-01 to 2017-03-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2016-07-01 to 2017-03-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-01-01 to 2017-03-31 | −$7.5k | us-gaap:NetIncomeLoss |
| Net income | 9 months2016-07-01 to 2017-03-31 | −$26.4k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-01-01 to 2017-03-31 | −$0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2016-07-01 to 2017-03-31 | −$0.02 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2016-07-01 to 2017-03-31 | $0 | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2017-03-31 | $0 | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-03-31 | $0 | us-gaap:AssetsCurrent |
| Total assets | At period end2017-03-31 | $0 | us-gaap:Assets |
| Current liabilities | At period end2017-03-31 | $220.2k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-03-31 | $220.2k | us-gaap:Liabilities |
| Shareholders' equity | At period end2017-03-31 | −$220.2k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001010412-17-000033. Last ingested by Listed: Nov 11, 2026, 02:48 ET. Listed shows no prices and gives no investment advice.